The first results from the MRC COIN trial, the largest trial in advanced bowel cancer carried out to date, will be presented at the National Cancer Research Institute annual conference in Birmingham on 6 October. The results provide more information about the potential effect different treatment options can have and so will help patients and clinicians to make treatment decisions.